BDBM50406136 CHEMBL5278676::US20250026762, Compound 59

SMILES FC(F)(F)c1cnn(c1)-c1nn(C(=O)N2CCN3CCC2CC3)c2CCOCc12

InChI Key InChIKey=DXCRLSOELNXSLW-UHFFFAOYSA-N

Data  2 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50406136   

TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406136(CHEMBL5278676 | US20250026762, Compound 59)
Affinity DataIC50: 32nMAssay Description:Inhibition of GCS in human fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 3A(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406136(CHEMBL5278676 | US20250026762, Compound 59)
Affinity DataIC50: 7.47E+3nMAssay Description:Antagonist activity at human 5HT3A expressed in HEK293 cells incubated for 1 hr by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406136(CHEMBL5278676 | US20250026762, Compound 59)
Affinity DataEC50:  3.10nMAssay Description:Using Promega's UDP-Glo™ Glycosyltransferase assay kit (Promega Corporation, Madison, WI, USA (Promega)), GCS activity was indirectly measured by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/30/2025
Entry Details
Go to US Patent